Elevation Wealth Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Elevation Wealth Partners's LH Position: Q2 2026 in Review
Elevation Wealth Partners reduced its Labcorp (LH) stake by 1.9% in Q2 2026, selling an estimated $3.42K and leaving 668 shares worth $187K. The position accounts for 0.06% of the portfolio, ranked #144.
Elevation Wealth Partners first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $219K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Elevation Wealth Partners held 668 shares of Labcorp worth $187K as of Q2 2026.
- Elevation Wealth Partners sold 13 Labcorp shares in Q2 2026, an estimated $3.42K.
- Labcorp made up 0.06% of Elevation Wealth Partners's portfolio in Q2 2026, its #144 holding.
- Elevation Wealth Partners first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
- Elevation Wealth Partners's Labcorp position peaked at $219K in Q3 2025.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.